Moderna won an agreement for its Covid vaccines in Europe on Friday, but Moderna stock reversed its early gains.

The FDA will review a new prefilled syringe presentation of Shingrix (zoster vaccine recombinant, adjuvanted).

The European Medicines Agency (EMA) has recommended granting marketing authorization for the pneumococcal vaccine Capvaxive ...

After two years characterized by layoffs, pipeline reorganizations, FDA delays and clinical holds, Novavax CEO John Jacobs ...

SINGAPORE: The updated JN.1 Novavax/Nuvaxovid COVID-19 vaccine will be offered under the national vaccination programme at selected Healthier SG general practitioner (GP) clinics until Apr 30.

We observed tasks in the vaccine preparation process, from the time of removal of the vial or the syringe package from the refrigerator until the time it was ready to be administered to a patient.

Back in November 2023, pharmaphorum travelled to Uppsala, Sweden, for a Novavax press conference, the company celebrating a decade of doing what it does best: vaccines. From COVID-19 to malaria ...

"Today, we announce the beginning of an exciting new chapter for Novavax with the launch of a strategically important partnership with one of the world's leading vaccine companies," NVAX CEO John ...

We recently compiled a list of the 10 Under-the-Radar Stocks with Massive Upside for 2025. In this article, we are going to ...

(Alliance News) - GSK PLC on Friday reported the US Food & Drug Administration has accepted its Shingrix vaccine syringe for review. The Brentford, England-based pharmaceutical and biotechnology ...

The most recent trading session ended with Novavax (NVAX) standing at $9.34 ... The the stock of vaccine maker has risen by 11.35% in the past month, leading the Medical sector's gain of 1. ...